ATE366810T1 - Menschliche p51-gene und deren genprodukte - Google Patents

Menschliche p51-gene und deren genprodukte

Info

Publication number
ATE366810T1
ATE366810T1 AT99910698T AT99910698T ATE366810T1 AT E366810 T1 ATE366810 T1 AT E366810T1 AT 99910698 T AT99910698 T AT 99910698T AT 99910698 T AT99910698 T AT 99910698T AT E366810 T1 ATE366810 T1 AT E366810T1
Authority
AT
Austria
Prior art keywords
genes
human
gene products
protein
recombinant
Prior art date
Application number
AT99910698T
Other languages
English (en)
Inventor
Yoji Ikawa
Shuntaro Ikawa
Masuo Obinata
Original Assignee
Otsuka Pharma Co Ltd
Yoji Ikawa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd, Yoji Ikawa filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of ATE366810T1 publication Critical patent/ATE366810T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT99910698T 1998-03-27 1999-03-24 Menschliche p51-gene und deren genprodukte ATE366810T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10046798 1998-03-27

Publications (1)

Publication Number Publication Date
ATE366810T1 true ATE366810T1 (de) 2007-08-15

Family

ID=14274724

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07013470T ATE512162T1 (de) 1998-03-27 1999-03-24 Antikörper gegen das p51 protein
AT99910698T ATE366810T1 (de) 1998-03-27 1999-03-24 Menschliche p51-gene und deren genprodukte

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07013470T ATE512162T1 (de) 1998-03-27 1999-03-24 Antikörper gegen das p51 protein

Country Status (13)

Country Link
US (4) US7132276B1 (de)
EP (2) EP1847607B1 (de)
JP (1) JP4336926B2 (de)
CN (1) CN100340665C (de)
AT (2) ATE512162T1 (de)
CA (1) CA2324649C (de)
CY (1) CY1111763T1 (de)
DE (1) DE69936513D1 (de)
DK (1) DK1847607T3 (de)
ES (1) ES2366234T3 (de)
HK (1) HK1034288A1 (de)
PT (1) PT1847607E (de)
WO (1) WO1999050412A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL147256A0 (en) * 1999-06-29 2002-08-14 Nippon Kayaku Kk Gene encoding promoter region of tumor suppressor gene p51 and use thereof
US7321881B2 (en) * 2004-02-27 2008-01-22 Aureon Laboratories, Inc. Methods and systems for predicting occurrence of an event
CN102181570A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定鼠遗传稳定性相关基因的专用引物及其应用
CN102181571A (zh) * 2011-05-20 2011-09-14 清华大学 辅助鉴定猪遗传稳定性相关基因的专用引物及其应用
CN104212879B (zh) * 2013-06-05 2016-09-21 上海派森诺生物科技股份有限公司 一种基于磁珠富集法高通量开发基因组ssr标记的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2744455B1 (fr) * 1996-02-02 1998-04-24 Sanofi Sa Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
AU7478098A (en) 1997-05-12 1998-12-08 Dana-Farber Cancer Institute Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies
AU1099699A (en) * 1997-10-15 1999-05-03 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
US7294459B1 (en) * 1997-10-15 2007-11-13 President And Fellows Of Harvard College Cell regulatory genes, encoded products, and uses related thereto
CA2323093A1 (en) 1998-03-18 1999-09-23 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6476206B1 (en) 1998-03-27 2002-11-05 The Johns Hopkins University p40 protein acts as an oncogene
DE19822985C1 (de) 1998-05-25 2000-01-13 Fraunhofer Ges Forschung Tumorsuppressorgene der p53-Familie

Also Published As

Publication number Publication date
US7754857B2 (en) 2010-07-13
WO1999050412A1 (fr) 1999-10-07
EP1847607A1 (de) 2007-10-24
EP1065270A1 (de) 2001-01-03
HK1034288A1 (en) 2001-10-19
CA2324649C (en) 2007-05-15
US20060115852A1 (en) 2006-06-01
ES2366234T3 (es) 2011-10-18
EP1065270B1 (de) 2007-07-11
JP4336926B2 (ja) 2009-09-30
DE69936513D1 (de) 2007-08-23
US20090142783A1 (en) 2009-06-04
CY1111763T1 (el) 2015-10-07
US20100285499A1 (en) 2010-11-11
US7132276B1 (en) 2006-11-07
PT1847607E (pt) 2011-08-25
CA2324649A1 (en) 1999-10-07
EP1065270A4 (de) 2004-12-29
CN1295615A (zh) 2001-05-16
US7553933B2 (en) 2009-06-30
CN100340665C (zh) 2007-10-03
EP1847607B1 (de) 2011-06-08
US7964367B2 (en) 2011-06-21
DK1847607T3 (da) 2011-07-18
ATE512162T1 (de) 2011-06-15

Similar Documents

Publication Publication Date Title
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
ATE335078T1 (de) Überexpression von säugetier- und virusproteinen
ATE382055T1 (de) Wnt-1 verwandte polypeptide und dafür kodierende nukleinsäuren
BR9507594A (pt) Processo para o tratamento de glomerulonefrite em um paciente necessitado deste tratamento artigo de fabricação anticorpo hibridoma 5g.1;1 molécula deácido nucleico proteina isolada polipeptideo isolado vetor de ácido nucleico célula hospedeira recombinante processo para produzir um polipeptideo de anticorpo c5 isolado anticorpo anti-c5 isolado processo para produzir uma proteina de anticorpo anti-c5 isolado molécula de ácido nucleico isolada processo para produzir um anticorpo anti-c5 anticorpo anti-c5 fragmento 5g46k fragmento 5g27k peptideo 5g325aa isolado peptideo 5g200aa isolado oligopeptideo isolado processo para induzir um animal a produzir um anti-c5 processo para identificar um anticorpo anti-c5 e processo para tratar um paciente necessitado de inibiçao complemetar
DE59810198D1 (de) Myc-bindende Zinkfinger-Proteine, ihre Herstellung und ihre Verwendung
GB9722320D0 (en) Human cell cycle checkpoint proteins
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
CY1111763T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
NO980122D0 (no) Emaljematriksrelatert polypeptid
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
NO874704D0 (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
EP0723014A3 (de) cDNA des DOCK180 Gens und DOCK180 Protein
EP0723016A3 (de) Leukocyten-aktivierender Faktor
WO2003018806A1 (fr) Nouveau gene humain bmcc1
ATE335005T1 (de) Menschliches protein mit in vitro antiproliferativer aktivität.
WO2003099995A3 (en) Murine ortholog of the human disrupted-in-schizophrenia 1 gene
CO5070672A1 (es) Polipeptido de proteina c humana
AU7871101A (en) Nucleic acids and proteins showing increased expression dose under salt stress
WO2002024913A3 (en) 32612, a novel human peptide transporter and uses therefor
WO2000063370A3 (en) Nucleic acids coding for novel truncated cart proteins, corresponding truncated cart polypeptides and their use for therapeutic and diagnostic purposes
WO2001046412A3 (de) Interaktionsprotein für stat transkriptionsfaktor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties